Perspective discusses engineering artificial cell systems using microfluidics to enable consistent self-assembly, suggesting a paradigm shift for manufacturing.
Bottom-up synthetic biology has achieved remarkable success in designing molecular architectures at the nanoscale. However, constructing functional, cell-sized artificial systems at the mesoscale remains a significant challenge due to the stochastic nature of pure molecular self-assembly. Natural cells overcome this thermodynamic limitation by employing active, energy-consuming mechanisms to maintain size, identity, and structural hierarchy. In this Perspective, I argue that, to construct consistent and robust molecular systems that can withstand practical use, we must seek a synergy between intrinsic self-assembly and deterministic engineering. Microfluidics should be viewed not merely as a replacement for biological regulation, but as a platform that provides extrinsic physical boundary conditions to guide and amplify the potential of molecular self-assembly. By categorizing microfluidic platforms into four hierarchical levels─from molecular assembly to multicellular bodies─I illustrate how engineering can recapitulate or replace complex biological regulatory systems. Finally, I discuss the necessary paradigm shift from bespoke laboratory craftsmanship to standardized biofoundries, outlining the applications and manufacturing breakthroughs required to democratize artificial cell technology for industrial and biomedical applications.
No takes yet. Share an insight, caveat, or question.
Hiroaki Suzuki (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: